GB0111004D0 - Screening method - Google Patents

Screening method

Info

Publication number
GB0111004D0
GB0111004D0 GBGB0111004.8A GB0111004A GB0111004D0 GB 0111004 D0 GB0111004 D0 GB 0111004D0 GB 0111004 A GB0111004 A GB 0111004A GB 0111004 D0 GB0111004 D0 GB 0111004D0
Authority
GB
United Kingdom
Prior art keywords
screening method
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0111004.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sheffield filed Critical University of Sheffield
Priority to GBGB0111004.8A priority Critical patent/GB0111004D0/en
Publication of GB0111004D0 publication Critical patent/GB0111004D0/en
Priority to PCT/GB2002/001946 priority patent/WO2002090992A2/en
Priority to AU2002249467A priority patent/AU2002249467A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB0111004.8A 2001-05-04 2001-05-04 Screening method Ceased GB0111004D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0111004.8A GB0111004D0 (en) 2001-05-04 2001-05-04 Screening method
PCT/GB2002/001946 WO2002090992A2 (en) 2001-05-04 2002-04-29 Screening method
AU2002249467A AU2002249467A1 (en) 2001-05-04 2002-04-29 Screening method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0111004.8A GB0111004D0 (en) 2001-05-04 2001-05-04 Screening method

Publications (1)

Publication Number Publication Date
GB0111004D0 true GB0111004D0 (en) 2001-06-27

Family

ID=9914069

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0111004.8A Ceased GB0111004D0 (en) 2001-05-04 2001-05-04 Screening method

Country Status (3)

Country Link
AU (1) AU2002249467A1 (en)
GB (1) GB0111004D0 (en)
WO (1) WO2002090992A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7883891B2 (en) 2001-07-17 2011-02-08 Massachusetts Institute Of Technology Unique properties of stem cells
US7193069B2 (en) 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
DE10319478A1 (en) * 2003-04-30 2004-11-18 Universität Zu Köln siRNA selection process
US7618936B2 (en) 2004-05-21 2009-11-17 The Regents Of The University Of California Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1)
US9045553B2 (en) 2004-05-27 2015-06-02 Acceleron Pharma, Inc. Cerberus/Coco derivatives and uses thereof
US7316998B2 (en) 2004-05-27 2008-01-08 Acceleron Pharma Inc. Cerberus/Coco derivatives and uses thereof
US7655465B2 (en) 2004-06-07 2010-02-02 Massachusetts Institute Of Technology Methods for ex vivo propagation of somatic hair follicle stem cells
AU2006261850B2 (en) * 2005-06-22 2011-06-16 Cxr Biosciences Limited Reporter hepatocytes and other cells for drug screening and toxicity testing
US7824912B2 (en) 2005-06-23 2010-11-02 Massachusetts Institute Of Technology Methods for ex vivo propagation of adult hepatic stem cells
WO2008073351A2 (en) 2006-12-08 2008-06-19 Acceleron Pharma Inc. Uses of cerberus, coco and derivatives thereof
WO2015017767A1 (en) * 2013-08-02 2015-02-05 University Of Georgia Research Foundation, Inc. Cryptosporidium transfection methods and transfected cryptosporidium cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69738996D1 (en) * 1996-05-30 2008-10-30 Cellomics Inc MINIATURIZED CELL ARRANGEMENT AND METHOD AND DEVICE FOR SCREENING BY CELLS
JP3683591B2 (en) * 1997-02-27 2005-08-17 セロミックス インコーポレイテッド Cell-based screening system
WO2001007891A2 (en) * 1999-07-27 2001-02-01 Cellomics, Inc. Miniaturized cell array methods and apparatus for cell-based screening
IL148421A0 (en) * 1999-09-13 2002-09-12 American Home Prod Pharmaceutical compositions and methods of using secreted frizzled related protein

Also Published As

Publication number Publication date
AU2002249467A1 (en) 2002-11-18
WO2002090992A2 (en) 2002-11-14
WO2002090992A3 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
EP1378749A4 (en) Screening method
GB0109993D0 (en) Method
GB0115243D0 (en) Method
GB0109049D0 (en) Method
GB0111004D0 (en) Screening method
GB0103998D0 (en) Method
GB0116453D0 (en) Method
GB0114629D0 (en) Method
GB0110547D0 (en) Method
GB0101762D0 (en) Method
GB0108349D0 (en) Method
AU2002354247A1 (en) Screening method
GB0101763D0 (en) Method
GB0116142D0 (en) Method
GB0102947D0 (en) Method
GB0205755D0 (en) Screening method
GB0111987D0 (en) Method
GB0102928D0 (en) Screening method
GB0116737D0 (en) Screening method
GB0029373D0 (en) Screening method
AU2003248955A8 (en) Screening method
GB0004629D0 (en) Screening method
GB0030504D0 (en) Screening method
GB0031273D0 (en) Screening method
SI1305636T1 (en) Screening method

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application
AT Applications terminated before publication under section 16(1)